Study on Chenopodiastrum hybridum’s Anti-inflammatory and Antioxidant Effects in Zebrafish: Mechanism Against Ovarian Cancer
Planta Medica · 23.10.2026
DOI: 10.1055/a-2978-8081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 23.10.2026. Verfasst von Shuli Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Jilin University, Department of Obstetrics and Gynecology, China, Changchun. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Jilin Science and Technology Development Plan Project, Development Plan Project of Education Department of Jilin Province, Jilin Province Department of Finance.
Abstract (Originalsprache)
Chenopodiastrum hybridum (CH) is an edible and folk medicinal plant, yet its efficacy and molecular mechanisms against ovarian cancer (OC) remain unclear, restricting its antitumor application. This study investigated the anti-OC effects and underlying mechanisms of CH via dose-effect weighted network pharmacology to provide experimental evidence for its clinical and medicinal development. This study determined the total flavonoid content of CH refined extract (CHRE) and assessed its inhibitory effect on OVCAR-3 cell proliferation. CHRE’s antioxidant and anti-inflammatory activities were evaluated by free-radical scavenging ability and detection of ROS, NO, TNF-α, and IL-6 levels. Network pharmacology, molecular docking, and molecular dynamics simulations were applied to screen core targets and key pathways, with RT-qPCR verifying target gene expression. Flavonoid-rich CHRE significantly inhibited OVCAR-3 cell growth, exhibiting potent antioxidant and anti-inflammatory activities. The estrogen signaling pathway was identified as the core regulatory pathway. CH’s key active compounds bound stably to the core targets (epidermal growth factor receptor [EGFR], ESR1, SRC, HSP90AA1, AKT1). RT-qPCR revealed downregulated mRNA levels of EGFR, AKT1, KDR, ESR1, and upregulated HSP90AA1 expression. CH suppresses OC proliferation by activating the estrogen signaling pathway to alleviate oxidative stress and inflammation. This study elucidates CH’s anti-OC mechanism, offering valuable references for developing novel natural botanical drugs and auxiliary clinical therapies for OC.
Autor:innen und Institutionen
- The Second Hospital of Jilin University, Department of Obstetrics and Gynecology, China, Changchun.
- Changchun University of Chinese Medicine, Jilin Ginseng Academy, China, Changchun.
- Pharmaron Beijing Co. Ltd., Pharmaron Beijing, China, Beijing.
- Baicheng Medical College, Baicheng Glycyrrhiza Research Institute, Jilin, China, Baicheng.
ORCID-Profile: Jiaming Sun
Förderung
- Jilin Science and Technology Development Plan Project
- Development Plan Project of Education Department of Jilin Province
- Jilin Province Department of Finance
Zitieren
APA
Yang, S., Feng, X., Wu, P., Cheng, D., Sun, J., & Lin, R. (2026). Study on Chenopodiastrum hybridum’s Anti-inflammatory and Antioxidant Effects in Zebrafish: Mechanism Against Ovarian Cancer. Planta Medica. https://doi.org/10.1055/a-2978-8081
Vancouver
Yang S, Feng X, Wu P, Cheng D, Sun J, Lin R. Study on Chenopodiastrum hybridum’s Anti-inflammatory and Antioxidant Effects in Zebrafish: Mechanism Against Ovarian Cancer. Planta Medica. 2026. doi:10.1055/a-2978-8081
BibTeX
@article{Yang2026,
author = {Yang, Shuli and Feng, Xueqin and Wu, Peitong and Cheng, Duanduan and Sun, Jiaming and Lin, Ruixin},
title = {Study on Chenopodiastrum hybridum’s Anti-inflammatory and Antioxidant Effects in Zebrafish: Mechanism Against Ovarian Cancer},
journal = {Planta Medica},
year = {2026},
doi = {10.1055/a-2978-8081}
}
EUVIMED